Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Numinus Wellness Inc (NUMIF)

Numinus Wellness Inc (NUMIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade NUMIF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0280 +28.21%
on 07/15/24
0.0529 -32.14%
on 06/21/24
-0.0019 (-5.03%)
since 06/18/24
3-Month
0.0251 +43.03%
on 06/05/24
0.0670 -46.42%
on 04/26/24
-0.0246 (-40.66%)
since 04/19/24
52-Week
0.0251 +43.03%
on 06/05/24
0.1886 -80.97%
on 07/20/23
-0.1470 (-80.37%)
since 07/19/23

Most Recent Stories

More News
Numinus Wellness Inc. Announces Third Quarter Fiscal 2024 Results

Q3 Fiscal 2024 Highlights Revenue of $4.3 million, a 1.9% decline over Q2 2024 Gross profit of $1.0 million, a 9.8% decline over Q2 2024 Cash position of $3.7...

NUMIF : 0.0359 (+10.46%)
NUMI.TO : 0.0450 (unch)
Numinus to Host Q3 Fiscal 2024 Results Conference Call on July 11, 2024

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...

NUMI.TO : 0.0450 (unch)
NUMIF : 0.0359 (+10.46%)
Numinus Wellness Announces Resignation of Director

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and...

NUMIF : 0.0359 (+10.46%)
NUMI.TO : 0.0450 (unch)
Numinus Wellness Announces Strategic Acquisition of MedBright AI

Plans name change to "Numinus Intelligence" leveraging its current revenue-generating operations to AI-enable mental health clinics across the U.S. The...

NUMIF : 0.0359 (+10.46%)
MBAI.CN : 0.0750 (unch)
NUMI.TO : 0.0450 (unch)
Numinus Clarifies Disclosures

Vancouver, British Columbia--(Newsfile Corp. - June 7, 2024) - Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus" or the "Company"), a mental health care company advancing traditional and innovative...

NUMIF : 0.0359 (+10.46%)
NUMI.TO : 0.0450 (unch)
Numinus Wellness Comments on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a leader in mental health care specializing in innovative and...

NUMIF : 0.0359 (+10.46%)
NUMI.TO : 0.0450 (unch)
Numinus Wellness Announces Voting Results From its Annual General Meeting of Shareholders

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...

NUMIF : 0.0359 (+10.46%)
NUMI.TO : 0.0450 (unch)
Numinus and Cybin Embark on a Groundbreaking Journey: Pioneering Phase 3 Trials for Major Depressive Disorder

Vancouver, British Columbia--(Newsfile Corp. - May 30, 2024) - In a significant stride towards transforming mental health care, Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23) has proudly...

NUMIF : 0.0359 (+10.46%)
NUMI.TO : 0.0450 (unch)
Numinus Wellness Charts Path To Profitability While Strengthening Community Ties

Vancouver, British Columbia--(Newsfile Corp. - May 30, 2024) - Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus'' or the "Company"), a leader in mental health care and in advancing evidence-based...

NUMIF : 0.0359 (+10.46%)
NUMI.TO : 0.0450 (unch)
Numinus Wellness Receives Health Canada Approval for Study into Group Model for MDMA-Assisted Therapy

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...

NUMIF : 0.0359 (+10.46%)
NUMI.TO : 0.0450 (unch)

Key Turning Points

3rd Resistance Point 0.0404
2nd Resistance Point 0.0382
1st Resistance Point 0.0370
Last Price 0.0359
1st Support Level 0.0336
2nd Support Level 0.0314
3rd Support Level 0.0302

See More

52-Week High 0.1886
Fibonacci 61.8% 0.1261
Fibonacci 50% 0.1068
Fibonacci 38.2% 0.0876
Last Price 0.0359
52-Week Low 0.0251

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar